Lindbrook Capital’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
Lindbrook Capital's NEO Position: Q1 2025 in Review
Lindbrook Capital increased its NeoGenomics (NEO) stake by 12% in Q1 2025, buying an estimated $375 and bringing the position to 280 shares worth $2.66K. The position accounts for ﹤0.01% of the portfolio, ranked #2196.
Lindbrook Capital first reported a position in NEO in Q3 2020 and has held it in 17 quarters since. The position peaked at $84K in Q4 2021. 256 funds tracked by Wall St. Rank hold NEO as of Q1 2025.
- Lindbrook Capital held 280 shares of NeoGenomics worth $2.66K as of Q1 2025.
- Lindbrook Capital bought 30 NeoGenomics shares in Q1 2025, an estimated $375.
- NeoGenomics made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2196 holding.
- Lindbrook Capital first reported a position in NeoGenomics in Q3 2020 and has held it in 17 quarters since.
- Lindbrook Capital's NeoGenomics position peaked at $84K in Q4 2021.
- 256 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2025.
Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.